Republic of Korea (ROK) started supplying Gilead's antiviral drug for the treatment of the novel coronavirus on July 1, the Korea Centers for Disease Control and Prevention (KCDC) said.
Illustrative Image (Source: Reuters).
The first batch of remdesivir will come from Gilead's donation until July, while the health authorities will negotiate the price for supply after August, KCDC said in a statement.